These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38980731)

  • 1. Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome.
    Sim JJ; Smoyer WE; Schachter AD
    Kidney360; 2024 Aug; 5(8):1197-1199. PubMed ID: 38980731
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
    Trachtman H; Laskowski J; Lee C; Renner B; Feemster A; Parikh S; Panzer SE; Zhong W; Cravedi P; Cantarelli C; Kulik L; You Z; Satchell S; Rovin B; Liu F; Kalled SL; Holers VM; Jalal D; Thurman JM
    Am J Physiol Renal Physiol; 2021 Oct; 321(4):F505-F516. PubMed ID: 34459222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies Targeting Nephrin in Podocytopathies.
    Hengel FE; Dehde S; Lassé M; Zahner G; Seifert L; Schnarre A; Kretz O; Demir F; Pinnschmidt HO; Grahammer F; Lucas R; Mehner LM; Zimmermann T; Billing AM; Oh J; Mitrotti A; Pontrelli P; Debiec H; Dossier C; Colucci M; Emma F; Smoyer WE; Weins A; Schaefer F; Alachkar N; Diemert A; Hogan J; Hoxha E; Wiech T; Rinschen MM; Ronco P; Vivarelli M; Gesualdo L; Tomas NM; Huber TB;
    N Engl J Med; 2024 Aug; 391(5):422-433. PubMed ID: 38804512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies Targeting Nephrin in Podocytopathies.
    Gleeson PJ; Monteiro RC
    N Engl J Med; 2024 Oct; 391(14):1365. PubMed ID: 39383467
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies Targeting Nephrin in Podocytopathies.
    Bruschi M; Angeletti A; Ghiggeri GM
    N Engl J Med; 2024 Oct; 391(14):1366. PubMed ID: 39383469
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibodies Targeting Nephrin in Podocytopathies.
    Berg AH; Karumanchi SA
    N Engl J Med; 2024 Oct; 391(14):1365-1366. PubMed ID: 39383468
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinicopathologic correlation of C1q nephropathy in children.
    Fukuma Y; Hisano S; Segawa Y; Niimi K; Tsuru N; Kaku Y; Hatae K; Kiyoshi Y; Mitsudome A; Iwasaki H
    Am J Kidney Dis; 2006 Mar; 47(3):412-8. PubMed ID: 16490619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1984; 23(4):14-21. PubMed ID: 6390968
    [No Abstract]   [Full Text] [Related]  

  • 9. An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy.
    Shappell SB; Myrthil G; Fogo A
    Am J Kidney Dis; 1997 Jun; 29(6):966-70. PubMed ID: 9186086
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterisation of renal immune cell infiltrates in children with nephrotic syndrome.
    Benz K; Büttner M; Dittrich K; Campean V; Dötsch J; Amann K
    Pediatr Nephrol; 2010 Jul; 25(7):1291-8. PubMed ID: 20386928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology, clinical presentations, and outcomes of C1q nephropathy.
    Vizjak A; Ferluga D; Rozic M; Hvala A; Lindic J; Levart TK; Jurcić V; Jennette JC
    J Am Soc Nephrol; 2008 Nov; 19(11):2237-44. PubMed ID: 18650484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
    Voznesenskaia TS; Sergeeva TV
    Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover.
    Colucci M; Oniszczuk J; Vivarelli M; Audard V
    Front Immunol; 2022; 13():823204. PubMed ID: 35140723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 15. Basophil sensitisation in idiopathic nephrotic syndrome.
    Pirotzky E; Hieblot C; Benveniste J; Laurent J; Lagrue G; Noirot C
    Lancet; 1982 Feb; 1(8268):358-61. PubMed ID: 6120348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Class II human leukocyte antigens in minimal change nephrotic syndrome and focal segmental glomerulosclerosis--preliminary study].
    Krasowska-Kwiecień A; Sancewicz-Pach K; Pogan A
    Pol Merkur Lekarski; 2001 Apr; 10(58):256-8. PubMed ID: 11434170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of T and B lymphocytes in glomerulopathy with minimal lesions].
    Sasdelli M; Cagnoli L; Rovinetti C; Beltrandi E; Catizone L; Zucchelli P
    Minerva Nefrol; 1979; 26(2):145-9. PubMed ID: 314073
    [No Abstract]   [Full Text] [Related]  

  • 18. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.
    Kazi JI; Mubarak M; Ahmed E; Akhter F; Naqvi SA; Rizvi SA
    Clin Exp Nephrol; 2009 Feb; 13(1):38-43. PubMed ID: 18685922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.
    Taube D; Chapman S; Brown Z; Williams DG
    Clin Nephrol; 1981 Jun; 15(6):286-90. PubMed ID: 7249426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.